中医药调控JAK/STAT3通路防治卵巢癌中的研究进展
Research Progress in the Regulation of JAK/STAT3 Pathway in Chinese Medicine to Treat Ovarian Cancer
DOI: 10.12677/TCM.2023.121035, PDF,   
作者: 高立群, 韦 康*：上海市普陀区真如镇街道社区卫生服务中心，上海
关键词: 卵巢癌；中医药；JAK/STAT3；Ovarian Cancer； Traditional Chinese Medicine； JAK/STAT3
摘要: 卵巢癌因其有限的治疗手段，严重危害女性健康，且多数患者进行手术和化疗患者多出现复发、转移和耐药性。与西医相比，中医药因其多靶点、多途径、高效低毒等优势备受关注。众多研究表明JAK/STAT3通路通过调控炎症、凋亡、抑制细胞增殖和生长等多方面参与卵巢癌形成、发生和发展。然而，目前未见系统的回顾与综述。因此，本文旨在综述中医药通过调控JAK/STAT3通路防治卵巢癌的研究进展，为进一步提高卵巢癌患者临床诊疗提供理论基础。
Abstract: Ovarian cancer seriously endangers women’s health due to its limited treatment, and most pa-tients who undergo surgery and chemotherapy mostly experience recurrence, metastasis and drug resistance. Compared with Western medicine, Chinese medicine has attracted much atten-tion because of its advantages such as multi-target, multiple pathways, high efficiency and low toxicity. Numerous studies have shown that the JAK/STAT3 pathway is involved in ovarian cancer formation, occurrence and progression through regulation of inflammation, apoptosis, and inhibition of cell proliferation and growth in many ways. However, a systematic review and synthesis is not available. Therefore, the aim of this paper is to review the research progress of Chinese medicine in the prevention and treatment of ovarian cancer through the regulation of JAK/STAT3 pathway, and to provide a theoretical basis for further improving the clinical treatment of ovarian cancer patients.
文章引用：高立群, 韦康. 中医药调控JAK/STAT3通路防治卵巢癌中的研究进展[J]. 中医学, 2023, 12(1): 215-220. https://doi.org/10.12677/TCM.2023.121035

参考文献

[1] Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[4] Khurana, A., Roy, D., Kalogera, E., et al. (2015) Quinacrine Promotes Autophagic Cell Death and Chemosensitivity in Ovarian Cancer and Attenuates Tumor Growth. Oncotarget, 6, 36354-36369. [Google Scholar] [CrossRef] [PubMed]
[5] Armstrong, D.K., Alvarez, R.D., Bakkum-Gamez, J.N., et al. (2021) Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 19, 191-226. [Google Scholar] [CrossRef] [PubMed]
[6] Kim, B.I., Kim, J.H., Sim, D.Y., et al. (2019) Inhibition of JAK2/STAT3 and Activation of Caspase9/3 Are Involved in KYS05090S-Induced Apoptosis in Ovarian Cancer Cells. International Journal of Oncology, 55, 203-210. [Google Scholar] [CrossRef] [PubMed]
[7] Leonard, W.J. and O’Shea, J.J. (1998) JAKS AND STATS: Biological Implications. Annual Review of Immunology, 16, 293-322. [Google Scholar] [CrossRef] [PubMed]
[8] Jin, W. (2020) Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epitheli-al-Mesenchymal Transition. Cells, 9, 217. [Google Scholar] [CrossRef] [PubMed]
[9] Silver, D.L., Naora, H., Liu, J., et al. (2004) Activated Signal Transducer and Activator of Transcription (STAT) 3: Localization in Focal Adhesions and Function in Ovarian Cancer Cell Motility. Cancer Research, 64, 3550-3558. [Google Scholar] [CrossRef] 
[10] Wen, W., Liang, W.J., et al. (2014) Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer. Molecular Cancer Therapeutics, 13, 3037-3048. [Google Scholar] [CrossRef] 
[11] 薛刚, 邹玺, 周锦勇, 等. 竹节香附素A对人胃癌细胞株BGC-823细胞周期及STAT3信号通路的影响[J]. 南京中医药大学学报, 2017, 33(1): 78-81.
[12] 樊素珍, 赵书君, 秦巧红, 等. 竹节香附素A通过JAK/STAT3通路抑制卵巢癌SKOV3细胞增殖和侵袭的实验研究[J]. 临床研究, 2021, 29(10): 1-5.
[13] 汤欣, 韩凤娟, 李威, 等. 莪术醇对人卵巢癌SKOV3细胞株JAK2/STAT3信号通路影响的研究[J]. 中国妇产科临床杂志, 2013(1): 43-46.
[14] Xu, X., Shi, J., Gao, H., et al. (2018) Zeylenone Inhibits Proliferation and Promotes Apoptosis in Ovarian Carcinoma Cells via Janus Kinase 2/Signal Transducers and Activators of Transcription 3 Pathways. Journal of Obstetrics and Gynaecology Research, 44, 1451-1457. [Google Scholar] [CrossRef] [PubMed]
[15] 任晶晶, 姬艳飞, 王静芳. 白头翁皂苷B4通过调控JAK/STAT3信号通路抑制SKOV3细胞增殖并诱导凋亡的研究[J]. 中华内分泌外科杂志, 2022, 16(1): 89-92.
[16] 李根林,刘杰, 谢晶, 等. 白藜芦醇通过调控IL-6/JAK2/STAT3信号通路对卵巢癌SKOV-3细胞增殖, 凋亡, 迁移和侵袭的影响[J].安徽医科大学学报, 2020, 55(5): 706-711.
[17] Ferraresi, A., Esposito, A., Girone, C., et al. (2021) Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells, 10, 3213. [Google Scholar] [CrossRef] [PubMed]
[18] 何超月, 任黔川. 吉马酮调控JAK2/STAT3信号通路对卵巢癌SKOV3细胞增殖,迁移,侵袭的影响[J]. 解放军医学院学报, 2021, 42(8): 866-871.
[19] Zhong, Y., Le, F., Cheng, J., et al. (2021) Triptolide Inhibits JAK2/STAT3 Signaling and Induces Lethal Autophagy through ROS Generation in Cisplatin Resistant SKOV3/DDP Ovarian Cancer Cells. Oncology Reports, 45, 69. [Google Scholar] [CrossRef] [PubMed]
[20] 谢程, 李文亚, 彭莉. 醌茜素通过调控JAK2/STAT3信号通路对卵巢癌细胞增殖, 凋亡, 迁移和侵袭的影响[J]. 中国优生与遗传杂志, 2021, 29(9): 1213-1217.
[21] 周学敏. 槲皮素对人卵巢癌细胞-3增殖和凋亡的影响[J]. 中医学报, 2016, 31(218): 931-936.
[22] Saydmohammed, M., Joseph, D. and Syed, V. (2010) Curcumin Suppresses Constitutive Activation of STAT-3 by Up-Regulating Protein Inhibitor of Activated STAT-3 (PIAS-3) in Ovarian and Endometrial Cancer Cells. Journal of Cellular Biochemistry, 110, 447-456. [Google Scholar] [CrossRef] [PubMed]
[23] Seo, J.H., Jeeong, K.J., Oh, W.J., et al. (2010) Lysophosphatidic Acid Induces STAT3 Phosphorylation and Ovarian Cancer Cell Motility: Their Inhibition by Curcumin. Journal of Cellular Biochemistry, 288, 50-56. [Google Scholar] [CrossRef] [PubMed]
[24] Liu, L., Nam, S., Tian, Y., et al. (2011) 6-Bromoindirubin-3,-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells. Cancer Research, 71, 3972-3979. [Google Scholar] [CrossRef] 
[25] Liu, L., Gaboriau, D.N., Vougogianopoulou, K., et al. (2014) MLS-2384, a New 6-Bromoindirubin Derivative with Dual JAK/Src Kinase Inhibitory Activity, Suppresses Growth of Diverse Cancer Cells. Cancer Biology & Therapy, 15, 178-184. [Google Scholar] [CrossRef] [PubMed]
[26] 上官梦原, 赵菁, 陈俊宇, 等. 五味子脂A增强卡铂对人卵巢癌Skov3细胞的促凋亡作用及其机制[J]. 吉林大学学报: 医学版, 2018, 44(1): 83-89.
[27] Li, X., Tang, Z., Wen, L., et al. (2021) Matrine: A Review of Its Pharmacology, Pharmacokinetics, Toxicity, Clinical Application and Preparation Researches. Journal of Ethnopharmacology, 6, Article ID: 113682. [Google Scholar] [CrossRef] [PubMed]
[28] 张玺. 苦参碱抗肿瘤作用分子机制研究[D]: [博士学位论文]. 武汉: 华中科技大学, 2020.
[29] Muhammad, I., Abdur, R., Ali, K.I., et al. (2018) Thymoquinone: A Novel Strategy to Combat Cancer: A Review. Biomedicine & Pharmacotherapy, 106, 390-402. [Google Scholar] [CrossRef] [PubMed]
[30] 张丽, 朱蕾. 百里醌对人卵巢癌细胞株OVCAR-3增殖和凋亡的影响[J]. 现代妇产科进展, 2016(5): 345-348.
[31] 邱丽楠. 理冲生髓饮干预卵巢癌的临床与实验研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2010.
[32] 张艳. 理冲生髓饮有效组分对卵巢癌血管生成影响及JAK2/STAT3信号通路调控的机制研究[D]: [博士学位论文]. 哈尔滨: 黑龙江中医药大学, 2016.
[33] 李航, 杨蝶, 刘慧芝. 复方丹参滴丸靶向调节JAK2/STAT3途径抑制卵巢癌大鼠的机制研究[J]. 中华中医药学刊, 2019(9): 2269-2271.